TRVI R&D Expenses

Trevi Therapeutics Inc · R&D Expenses

TRVI logo

TRVI R&D Expenses

Latest reported$41.37M
TRVI R&D Expenses ($6.91M → $41.37M)
High-resolution chart · PNG

TRVI r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Trevi Therapeutics Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
33,478,000
39,377,000
23,683,000
19,834,000
22,984,000
22,328,000
19,339,000
14,072,000
6,095,000
6,913,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.